01 January 2024 31 December 2024 No principle activity is included 13822459 2024-01-01 13822459 2024-12-31 13822459 2024-01-01 2024-12-31 13822459 2023-12-31 13822459 2023-01-01 2023-12-31 13822459 uk-core:WithinOneYear 2024-12-31 13822459 uk-core:WithinOneYear 2023-12-31 13822459 uk-core:ShareCapital 2024-12-31 13822459 uk-core:ShareCapital 2023-12-31 13822459 uk-core:RetainedEarningsAccumulatedLosses 2024-12-31 13822459 uk-core:RetainedEarningsAccumulatedLosses 2023-12-31 13822459 uk-bus:Director1 2024-01-01 2024-12-31 13822459 uk-bus:FRS102 2024-01-01 2024-12-31 13822459 uk-bus:FullAccounts 2024-01-01 2024-12-31 13822459 uk-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13822459 uk-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  AESTHETICS-OCULOPLASTICS LIMITED
   
   
   
  UNAUDITED FINANCIAL STATEMENTS
   
   
   
  FOR THE YEAR ENDED 31 DECEMBER 2024
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  AESTHETICS-OCULOPLASTICS LIMITED
  Company registered number: 13822459
  STATEMENT OF FINANCIAL POSITION AT 31 December 2024
           
    Note 2024 2023
      £ £ £
  FIXED ASSETS
  Property, plant & equipment 3,720 4,413
           
  CURRENT ASSETS
  Debtors   2,813 2,533
  Cash at bank   2,532 867
      5,345 3,400
  CREDITORS: Amounts falling due within one year   22,741 27,642
  NET CURRENT LIABILITIES   (17,396) (24,242)
  NET LIABILITIES   13,676) 19,829)
       
  CAPITAL AND RESERVES
  Called up share capital   100 100
  Retained earnings   (13,776) (19,929)
  SHAREHOLDERS' FUNDS   13,676) 19,829)
       
       
       
  In approving these financial statements as director of the company I hereby confirm the following:
       
  For the year in question the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
       
  The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with section 476 of the Companies Act 2006.
       
  The directors acknowledge their responsibilities for: 1) ensuring that the company keeps accounting records which comply with Sections 386 and 386 of the Companies Act 2006, and 2) preparing financial statements that give a true and fair view of the state of affairs of the company at at the end of each financial year and of its profit or loss for the financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to the financial statements, so far as they are applicable to the company.
 
 
  These financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies
       
  In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
       
  The financial statements were approved and authorised for issue by the board of directors on 24 February 2025
 
  Signed on behalf of the board of directors
 
 
       
  Dr I Pereni, Director
       
       
  The notes on pages 2 form part of these financial statements
   
  page 1
  AESTHETICS-OCULOPLASTICS LIMITED
  NOTES TO THE ACCOUNTS
  FOR THE YEAR ENDED 31 DECEMBER 2024
       
       
1. DIRECTORS AND EMPLOYEES
       
  The average weekly number of employees during the year were as follows:
    2024 2023
    No. No.
  Management & administration 1 1
   
  The notes on pages 2 form part of these financial statements
   
  page 2